Skip to main content

Table 1 Patients characteristics, major morbidities and respiratory support at 28 DOL

From: A modified physiologic test for bronchopulmonary dysplasia: a clinical tool for weaning from CPAP and/or oxygen-therapy the premature babies?

 

All infants (N 125)

Died infants (N 16)

Non tested infants (room air) (N 61)

Non tested infants (MV or FiO2 > 0.3) (N 25)

Failed Group (N 17)

Passed Group (N 6)

P1

P2

GA (wks)

28.0 ± 2.5

26.5 ± 1.5

29.8 ± 2.0

26.1 ± 1.4

26.5 ± 1.7

26.5 ± 1.8

< 0.0001

0.89

BW (g)

923 ± 234

752 ± 231

1061 ± 140

740 ± 227

856 ± 215

917 ± 187

< 0.0001

0.54

M/F

62/63

9/7

24/37

16/9

9/8

4/2

0.22

0.66

RDS

85 (68)

16 (100)

28 (46)

24 (96)

12 (70)

5 (83)

< 0.0001

1

PDA

15 (12)

2 (12)

0

7 (28)

5 (29)

1 (17)

0.0007

1

IVH > 2°

14 (11)

3 (19)

2 (3)

7 (28)

3 (18)

0

0.01

0.54

Sepsis

37 (30)

6 (37)

13 (21)

11 (44)

5 (29)

2 (33)

0.28

1

Survival

104 (83)

0

61 (100)

21 (84)

16 (94)

6 (100)

0.01

1

Neonates on CPAP

26 (21)

 

0

7 (28)

14 (82)

5 (83)

< 0.0001

1

Baseline FiO2

0.21 [0.21–0.55]

 

0.21 [0.21–0.21]

0.30 [0.21–0.55]

0.25 [0.21–0.30]

0.21 [0.21–0.23]

< 0.0001

0.03

  1. Values are expressed as mean ± SD, median [range] or number (%)
  2. P1: comparison between the groups; P2: comparison between the Failed and Passed groups
  3. GA gestational age, BW birth weight, RDS respiratory distress syndrome, PDA patent ductus arteriosus surgically ligated, IVH intraventricular hemorrhage, FiO2 Fraction of inspired oxygen, MV mechanical ventilation, CPAP continuous positive airways pressure, MV mechanical ventilation